Exagen Total Liabilities 2019-2024 | XGN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Exagen total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Exagen total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$194.8B
Boston Scientific (BSX)	$139.8B
Stryker (SYK)	$139.4B
EssilorLuxottica (ESLOY)	$110.1B
Medtronic (MDT)	$103.4B
Lonza Group Ag (LZAGY)	$43.7B
Haleon (HLN)	$41.2B
GE HealthCare Technologies (GEHC)	$38.7B
ResMed (RMD)	$34.3B
Terumo (TRUMY)	$28B
Koninklijke Philips (PHG)	$24.3B
Zimmer Biomet Holdings (ZBH)	$20.8B
Insulet (PODD)	$19.1B
Baxter (BAX)	$15B
Smith & Nephew SNATS (SNN)	$10.5B
Bio-Rad Laboratories (BIO)	$9.6B
BellRing Brands (BRBR)	$9.1B
Demant (WILYY)	$8.6B
Lantheus Holdings (LNTH)	$6.7B
Haemonetics (HAE)	$3.9B
ICU Medical (ICUI)	$3.8B
Prestige Consumer Healthcare (PBH)	$3.7B
Perrigo (PRGO)	$3.3B
Envista Holdings (NVST)	$3.2B
QuidelOrtho (QDEL)	$3.1B
Shandong Weigao Medical Polymer (SHWGF)	$3B
Neogen (NEOG)	$2.7B
GN Store Nord (GNNDY)	$2.6B
LeMaitre Vascular (LMAT)	$2.1B
Green Thumb Industries (GTBIF)	$1.6B